A mild increase in nutrient signaling to mTORC1 in mice leads to parenchymal damage, myeloid inflammation and shortened lifespan
- PMID: 38849535
- PMCID: PMC11333293
- DOI: 10.1038/s43587-024-00635-x
A mild increase in nutrient signaling to mTORC1 in mice leads to parenchymal damage, myeloid inflammation and shortened lifespan
Abstract
The mechanistic target of rapamycin complex 1 controls cellular anabolism in response to growth factor signaling and to nutrient sufficiency signaled through the Rag GTPases. Inhibition of mTOR reproducibly extends longevity across eukaryotes. Here we report that mice that endogenously express active mutant variants of RagC exhibit multiple features of parenchymal damage that include senescence, expression of inflammatory molecules, increased myeloid inflammation with extensive features of inflammaging and a ~30% reduction in lifespan. Through bone marrow transplantation experiments, we show that myeloid cells are abnormally activated by signals emanating from dysfunctional RagC-mutant parenchyma, causing neutrophil extravasation that inflicts additional inflammatory damage. Therapeutic suppression of myeloid inflammation in aged RagC-mutant mice attenuates parenchymal damage and extends survival. Together, our findings link mildly increased nutrient signaling to limited lifespan in mammals, and support a two-component process of parenchymal damage and myeloid inflammation that together precipitate a time-dependent organ deterioration that limits longevity.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures














Similar articles
-
Nutrient regulation of mTORC1 at a glance.J Cell Sci. 2019 Nov 13;132(21):jcs222570. doi: 10.1242/jcs.222570. J Cell Sci. 2019. PMID: 31722960 Free PMC article. Review.
-
Sestrins function as guanine nucleotide dissociation inhibitors for Rag GTPases to control mTORC1 signaling.Cell. 2014 Sep 25;159(1):122-133. doi: 10.1016/j.cell.2014.08.038. Cell. 2014. PMID: 25259925 Free PMC article.
-
Canagliflozin shares common mTOR and MAPK signaling mechanisms with other lifespan extension treatments.Life Sci. 2023 Sep 1;328:121904. doi: 10.1016/j.lfs.2023.121904. Epub 2023 Jul 3. Life Sci. 2023. PMID: 37406767 Free PMC article.
-
1,25-Dihydroxyvitamin D3 induces human myeloid cell differentiation via the mTOR signaling pathway.Biochem Biophys Res Commun. 2019 Nov 19;519(4):909-915. doi: 10.1016/j.bbrc.2019.09.100. Epub 2019 Sep 25. Biochem Biophys Res Commun. 2019. PMID: 31563324
-
mTOR Complex 1 Content and Regulation Is Adapted to Animal Longevity.Int J Mol Sci. 2022 Aug 6;23(15):8747. doi: 10.3390/ijms23158747. Int J Mol Sci. 2022. PMID: 35955882 Free PMC article. Review.
Cited by
-
Caloric restriction and its mimetics in heart failure with preserved ejection fraction: mechanisms and therapeutic potential.Cardiovasc Diabetol. 2025 Jan 18;24(1):21. doi: 10.1186/s12933-024-02566-8. Cardiovasc Diabetol. 2025. PMID: 39827109 Free PMC article. Review.
-
A nutrigeroscience approach: Dietary macronutrients and cellular senescence.Cell Metab. 2024 Sep 3;36(9):1914-1944. doi: 10.1016/j.cmet.2024.07.025. Epub 2024 Aug 22. Cell Metab. 2024. PMID: 39178854 Review.
-
Developing a novel aging assessment model to uncover heterogeneity in organ aging and screening of aging-related drugs.Genome Med. 2025 Jul 24;17(1):83. doi: 10.1186/s13073-025-01501-0. Genome Med. 2025. PMID: 40708007 Free PMC article.
-
Inflammageing, a targetable pathway for preventing cardiovascular diseases.Cardiovasc Res. 2025 Aug 28;121(10):1537-1550. doi: 10.1093/cvr/cvae240. Cardiovasc Res. 2025. PMID: 39530590 Free PMC article. Review.
-
mTOR links nutrients, inflammaging and lifespan.Nat Aging. 2024 Aug;4(8):1034-1035. doi: 10.1038/s43587-024-00681-5. Nat Aging. 2024. PMID: 39060537 No abstract available.
References
-
- Suzman, R. & Beard, J. Global Health and Aging (World Health Organization, 2011).
MeSH terms
Substances
Grants and funding
- ERC-2014-STG-638891/EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council)
- LCF/PR/HR21/0046/"la Caixa" Foundation (Caixa Foundation)
- ID 100010434 LCF/BQ/DR19/11740022/"la Caixa" Foundation (Caixa Foundation)
- LABAE16001EFEY/AECC/Fundación Científica Asociación Española Contra el Cáncer (Scientific Foundation, Spanish Association Against Cancer)
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous